Literature DB >> 36038630

In CAR T cell-treated lymphomas, the T cell rich get richer.

Theodora Anagnostou1, Joshua D Brody2,3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36038630     DOI: 10.1038/s41591-022-01922-z

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   87.241


× No keyword cloud information.
  2 in total

Review 1.  Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy.

Authors:  Elizabeth R Hawkins; Reena R D'Souza; Astero Klampatsa
Journal:  Biologics       Date:  2021-04-14

2.  Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma.

Authors:  Nathalie Scholler; Regis Perbost; Frederick L Locke; Michael D Jain; Sarah Turcan; Corinne Danan; Edmund C Chang; Sattva S Neelapu; David B Miklos; Caron A Jacobson; Lazaros J Lekakis; Yi Lin; Armin Ghobadi; Jenny J Kim; Justin Chou; Vicki Plaks; Zixing Wang; Allen Xue; Mike Mattie; John M Rossi; Adrian Bot; Jérôme Galon
Journal:  Nat Med       Date:  2022-08-29       Impact factor: 87.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.